Technical Analysis for ALT - Altimmune, Inc.

Grade Last Price % Change Price Change
D 7.99 -4.88% -0.41
ALT closed down 4.88 percent on Friday, April 12, 2024, on 60 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down

Date Alert Name Type % Chg
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Outside Day Range Expansion -4.88%
Oversold Stochastic Weakness -4.88%
NR7 Range Contraction -0.25%
Narrow Range Bar Range Contraction -0.25%
Stochastic Reached Oversold Weakness -0.25%
Wide Bands Range Expansion -0.25%
Down 3 Days in a Row Weakness -0.25%
Gapped Down Weakness -0.25%

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Altimmune, Inc. Description

Altimmune,Inc., formerly Pharmathene, Inc., is a biodefense company. The Company is focused on the development of medical counter measures against biological and chemical threats. The Company is involved in the development of two next generation anthrax vaccines. The Company's anthrax vaccines use recombinant protective antigen (rPA) manufacturing processes. The Company's product portfolio includes recombinant butyrylcholinesterase (rBChE) bioscavenger, which is used in prevention and treatment of nerve agent poisoning. The Company has developed a recombinant form of human butyrylcholinesterase for pre- and post-exposure therapy to patients with nerve agent attacks. Its rBChE bioscavenger acts with mechanism, which includes reversal of the acute toxicity associated with organophosphate poisoning agents used in chemical warfare (cholinergic crisis). Its development program also includes Valortim for monoclonal human antibody treatment.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Phosphates Manufacturing Process Obesity Vaccines Reversal Manufacturing Processes Nerve Biodefense Choline Biological Warfare Anthrax Chemical Warfare Cholinesterase Anthrax Vaccines Athene

Is ALT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 14.84
52 Week Low 2.09
Average Volume 5,042,687
200-Day Moving Average 5.82
50-Day Moving Average 9.76
20-Day Moving Average 8.99
10-Day Moving Average 8.83
Average True Range 0.84
RSI (14) 39.39
ADX 15.82
+DI 17.16
-DI 28.23
Chandelier Exit (Long, 3 ATRs) 8.98
Chandelier Exit (Short, 3 ATRs) 10.27
Upper Bollinger Bands 10.20
Lower Bollinger Band 7.78
Percent B (%b) 0.09
BandWidth 26.90
MACD Line -0.46
MACD Signal Line -0.35
MACD Histogram -0.1088
Fundamentals Value
Market Cap 429.29 Million
Num Shares 53.7 Million
EPS -1.54
Price-to-Earnings (P/E) Ratio -5.19
Price-to-Sales 1976.80
Price-to-Book 3.74
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 8.86
Resistance 3 (R3) 8.88 8.60 8.72
Resistance 2 (R2) 8.60 8.38 8.60 8.67
Resistance 1 (R1) 8.30 8.24 8.16 8.28 8.62
Pivot Point 8.02 8.02 7.96 8.02 8.02
Support 1 (S1) 7.72 7.80 7.58 7.70 7.36
Support 2 (S2) 7.44 7.66 7.44 7.31
Support 3 (S3) 7.14 7.44 7.27
Support 4 (S4) 7.12